Current Price: $31.5 Price Target: $36
Position Size: 2.76% Trailing 12-month Performance: -5.7%
Q3 Highlights:
- Strong credit quality with credit loses reverting back to pre-pandemic levels and BAC released reserves for loan losses
- BAC actually released $858m reserves built up in anticipation for pandemic related losses, showing confidence in the recovery.
- Net charge-offs (loan losses) are back to pre-pandemic levels
- BAC has managed the pandemic well with strong credit performance.
- Largest deposit base in country with $885b in consumer deposits
- Deposit growth has surged up over 23% yoy
- Low cost source of funding. BAC pay only 4 bips on deposits.
- Net Interest income increased to $10.37b from $10.24b las quarter
- Net interest margin leveled off at 1.71% which they believe is the bottom
- Expect NIM to trend up as increased deposits are invested and balance sheet growth, though they noted reinvestment rates remain a headwind.
- NIM will remain depressed until we see a sustained economic recovery. At that point, banks will be among the industries most levered to benefit from the rebound.
- Excess capital – BAC is a return of capital story
- BAC has massive excess capital of $36B (13% of market cap) with a CET1 ratio of 11.9% which is 2.4% above required minimum
- BAC has approved a $3.2b share buyback for this quarter
- Current dividend yield is 2.28% for shareholder yield close to 7%.
- Fed’s stress test has consistently shown BAC losses to be lower than peers Strong capital ratios:
- Attractive valuation
- BAC has strong earnings power – generates over $5b a quarter in earnings
- BAC continues to build capital as share buybacks and dividend increases are restricted.
BAC Thesis:
- BAC has dramatically improved their Consumer Banking unit which has driven earning’s growth. Loss metrics are best among peers.
- Despite current recession, BAC has strong balance sheet and earnings power
- Their stronger capital position should lead to increased dividends and buybacks
Please let me know if you have questions.
Thanks,
John
[category Equity Earnings]
[tag BAC]
$BAC.US
John R. Ingram CFA
Chief Investment Officer
Partner
Direct: 617.226.0021
Fax: 617.523.8118
Crestwood Advisors
One Liberty Square
Suite 500
Boston, MA 02109